Conserved anchorless surface proteins as group A streptococcal vaccine candidates

References

Page 1

	Year	Citations
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. Vijay Pancholi, Vincent A. Fischetti The Journal of Experimental Medicine Protein AssemblyGlycobiologyBacteriologyMedical MicrobiologyBeta-nicotinamide Adenine	1992	631
α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci Vijaykumar Pancholi, Vincent A. Fischetti Journal of Biological Chemistry	1998	551
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection Mark J. Walker, Andrew Hollands, Martina Sanderson‐Smith, Nature Medicine Natural SciencesVirulence FactorPathogenesisMolecular BiologyDna Replication	2007	431
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome Manuel J. Rodríguez‐Ortega, Nathalie Norais, Giuliano Bensi, Nature Biotechnology VaccinationVaccine Candidate ProteinsReverse VaccinologyMedicineVaccine Target	2006	428
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci James B. Dale, Thomas A. Penfound, Edna Y. Chiang, Vaccine VaccinationImmunologyCross-opsonic AntibodiesNon-vaccine SerotypesMicrobiology	2011	259
Epitopes of streptococcal M proteins shared with cardiac myosin. James B. Dale, E H Beachey The Journal of Experimental Medicine Cardiac MuscleHumoral ResponseImmunologyPathologyAntigen Processing	1985	226
Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory Jonathan R. Carapetis, Don R Wolff, Bart J. Currie The Medical Journal of Australia	1996	222
Protection against Group A Streptococcus by Immunization with J8–Diphtheria Toxoid: Contribution of J8‐ and Diphtheria Toxoid–Specific Antibodies to Protection Michael R. Batzloff, Wendy A. Hayman, Mark R. Davies, The Journal of Infectious Diseases	2003	192
Invasive M1T1 group A <i>Streptococcus</i> undergoes a phase‐shift <i>in vivo</i> to prevent proteolytic degradation of multiple virulence factors by SpeB Ramy K. Aziz, M. Pabst, Arthur Jeng, Molecular Microbiology	2003	191
Glycolytic enzymes associated with the cell surface of <i>Streptococcus pneumoniae</i> are antigenic in humans and elicit protective immune responses in the mouse Eduard Ling, Galia Feldman, Maxim Portnoi, Clinical & Experimental Immunology Microbial PathogensInnate Immune SystemImmunologyImmunodominanceInnate Immunity	2004	184

Page 1